Triana Biomedicines Funding: $230M Raised, Series A (2022)
Triana Biomedicines is a Biotech company based in Lexington, Massachusetts. It has raised $230M in total funding. Latest round: Series A.
Triana Biomedicines funding overview
Triana Biomedicines is a Biotech company based in Lexington, Massachusetts. Triana Biomedicines has raised $230M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Triana Biomedicines runs through 2022; nothing later has been disclosed. Investors on record include RA Capital Management, Atlas Venture. 2 distinct backers are named across the disclosed rounds.
Triana Biomedicines at a glance
Total raised
$230M
Latest round
Series A
Latest round date
April 2022
Industry
Biotech
Headquarters
Lexington, Massachusetts
Notable investors
RA Capital Management, Atlas Venture
Frequently asked about Triana Biomedicines funding
How much has Triana Biomedicines raised?
Triana Biomedicines has raised $230M in total disclosed funding across the rounds on record.
Who has invested in Triana Biomedicines?
RA Capital Management, Atlas Venture are named among the investors backing Triana Biomedicines.
What was the latest Triana Biomedicines funding round?
The most recent disclosed round is a Series A, announced in April 2022.
Where is Triana Biomedicines based?
Triana Biomedicines is based in Lexington, Massachusetts.
What sector does Triana Biomedicines operate in?
Triana Biomedicines is tracked under Biotech from Lexington, Massachusetts, with $230M in disclosed funding.
When did Triana Biomedicines last raise?
The last disclosed Triana Biomedicines round closed in April 2022 at Series A.
Totals shown for Triana Biomedicines aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Lexington and the investors behind them below.
